跳至主要内容
临床试验/NCT04591236
NCT04591236已完成不适用

The Effect of Simultaneous Application of Transcranial Direct Current Stimulation (tDCS) and Gait Training for Parkinson's Disease Patients on Gait Function Improvement

Samsung Medical Center2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2020年11月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
2
主要终点
Change in 10 meter walk test from baseline in gait speed

研究概览

简要总结

The purpose of this study was to investigate the effect of simultaneous application of transcranial direct current stimulation (tDCS) and treadmill gait training for gait function recovery in Parkinson's disease patients with gait impairment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 50 - 75 years
  • Modified Hoehn and Yahr stages 1 to 4

排除标准

  • Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living)
  • Difficult to understand experimental tasks because of extremely severe cognitive impairment (Korean-Mini-Mental State Examination, K-MMSE≤10)
  • History of psychiatric disease
  • Implanted objects that would contraindicate tDCS

结局指标

主要结局

Change in 10 meter walk test from baseline in gait speed

时间窗: session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)]

Measure of self selected speeds by measuring the time it takes an individual to walk 10 meters. To perform the test, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: "Please walk this distance at your normal pace when I say go."

次要结局

  • Change in Berg Balance Scale (BBS) from baseline in balance(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)])
  • Change in Timed Up and Go test (TUG) from baseline in balance(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)])
  • Changes in Brain activation of resting-state functional MRI(session 0 (initial visit); session 10 (at approximately 4 weeks))
  • Changes in motor evoked potentia(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)])
  • Changes in Functional Reach Test (FRT) from baseline(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)])
  • Change in muscle manual test (MMT) and range of motion (ROM) from baseline(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)])
  • Change in Unified Parkinson's Disease Rating Scale (UPDRS) from baseline(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)])
  • Change in Korean Mini-Mental State Examination (K-MMSE) from baseline(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)])
  • Change in Geriatric Depression Scale (GDS) from baseline(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)])

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yun-Hee Kim

Professor

Samsung Medical Center

研究点 (2)

Loading locations...

相似试验